‡ In these countries please contact our distributor

Independent Non-Executive Director - Bob White

Appointed Independent Non-Executive Director on 1 May 2020. Bob was appointed as a Member of the Compliance & Culture Committee on 27 July 2020 and as a Member of the Remuneration Committee on 28 July 2020.

Career and Experience

Bob graduated from Cleveland State University in 1985 with a BBA in Marketing and went on to achieve an MBA from Case Western Reserve University. In addition, he is a Fellow of the American College of Healthcare Executives.

In 1986, Bob joined IBM Corporation and later progressed to become their Healthcare Solutions General Manager in 1995 for EMEA regions. Bob returned to the US in 1997 as a Global Marketing Executive for IBM’s healthcare business, with direct responsibility for managing marketing, M&A and sales strategies. Bob has held a number of senior Vice President positions throughout his career, including at Chemdex Corporation, Accelrys Inc., SourceOne Healthcare Technologies Inc., and GE Healthcare.

Prior to his time at Medtronic, he served in several increasingly senior roles with Covidien, including President, Emerging Markets and President, Respiratory and Monitoring Solutions. He then became Senior Vice President and President of Medtronic Asia Pacific, having led the integration of Covidien Asia Pacific when it was acquired by Medtronic in 2015. Bob is currently a member of the Medtronic Executive Committee and holds the position of Executive Vice President and President for their Minimally Invasive Therapies Group.

Other Current Appointments

  • Executive Vice President and President, Minimally Invasive Therapies Group at Medtronic plc.

Skills and Competencies

Bob is an experienced leader with more than 25 years’ worth of industry relevant experience. He is an influential and well-known figure in the medical technology sector and has an impressive track record in delivering growth and fostering innovation. He brings valuable global medical technology insight to the Board, which will prove fundamental in helping to shape and develop the future strategic direction of Smith+Nephew.